|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang B, Liao GQ, Wen XF, Chen WH, Cheng S,
Stolzenburg JU, Ganzer R and Neuhaus J: Nuclear magnetic resonance
spectroscopy as a new approach for improvement of early diagnosis
and risk stratification of prostate cancer. J Zhejiang Univ Sci B.
18:921–933. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ha Chung B, Horie S and Chiong E: The
incidence, mortality, and risk factors of prostate cancer in Asian
men. Prostate Int. 7:1–8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heidenreich A, Aus G, Bolla M, Joniau S,
Matveev VB, Schmid HP and Zattoni F; European Association of
Urology, : EAU guidelines on prostate cancer. Eur Urol. 53:68–80.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyamoto H, Messing EM and Chang C:
Androgen deprivation therapy for prostate cancer: Current status
and future prospects. Prostate. 61:332–353. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kirby M, Hirst C and Crawford ED:
Characterising the castration-resistant prostate cancer population:
A systematic review. Int J Clin Pract. 65:1180–1192. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Souza AG, Bastos VAF, Silva IBB, Marangoni
K and Goulart VA: Different gene therapy strategies: A overview for
prostate cancer. Curr Gene Ther. 16:287–291. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vaughan TY, Verma S and Bunting KD:
Grb2-associated binding (Gab) proteins in hematopoietic and immune
cell biology. Am J Blood Res. 1:130–134. 2011.PubMed/NCBI
|
|
9
|
Nyga R, Pecquet C, Harir N, Gu H,
Dhennin-Duthille I, Régnier A, Gouilleux-Gruart V, Lassoued K and
Gouilleux F: Activated STAT5 proteins induce activation of the PI
3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding
adapter. Biochem J. 390:359–366. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brown LA, Kalloger SE, Miller MA, Shih
IeM, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J,
Gilks CB and Huntsman DG: Amplification of 11q13 in ovarian
carcinoma. Genes Chromosomes Cancer. 47:481–489. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zatkova A, Schoch C, Speleman F, Poppe B,
Mannhalter C, Fonatsch C and Wimmer K: GAB2 is a novel target of
11q amplification in AML/MDS. Genes Chromosomes Cancer. 45:798–807.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sármay G, Angyal A, Kertész A, Maus M and
Medgyesi D: The multiple function of Grb2 associated binder (Gab)
adaptor/scaffolding protein in immune cell signaling. Immunol Lett.
104:76–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y and Rohrschneider LR: The gift of
Gab. FEBS Lett. 515:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ke Y, Wu D, Princen F, Nguyen T, Pang Y,
Lesperance J, Muller WJ, Oshima RG and Feng GS: Role of Gab2 in
mammary tumorigenesis and metastasis. Oncogene. 26:4951–4960. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing (version 3.6.0). (Vienna, Austria). 2019.URL
https://www.R-project.org/.
|
|
17
|
Felciano RM, Bavari S, Richards DR,
Billaud JN, Warren T, Panchal R and Krämer A: Predictive systems
biology approach to broad-spectrum, host-directed drug target
discovery in infectious diseases. Pac Symp Biocomput. 17–28.
2013.PubMed/NCBI
|
|
18
|
Calvano SE, Xiao W, Richards DR, Felciano
RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK,
et al: A network-based analysis of systemic inflammation in humans.
Nature. 437:1032–1037. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singal R, Ferdinand L, Reis IM and
Schlesselman JJ: Methylation of multiple genes in prostate cancer
and the relationship with clinicopathological features of disease.
Oncol Rep. 12:631–637. 2004.PubMed/NCBI
|
|
20
|
Xin-Hong G, Xiao-Cheng J and Liang-Bi C:
Gene chip technology and the studies of gene expression profiles. J
Biol. 2001.
|
|
21
|
Singh SK, Banerjee S, Acosta EP, Lillard
JW and Singh R: Resveratrol induces cell cycle arrest and apoptosis
with docetaxel in prostate cancer cells via a p53/p21WAF1/CIP1 and
p27KIP1 pathway. Oncotarget. 8:17216–17228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang T, Espenshade PJ, Wright ME, Yabe D,
Gong Y, Aebersold R, Goldstein JL and Brown MS: Crucial step in
cholesterol homeostasis: Sterols promote binding of SCAP to
INSIG-1, a membrane protein that facilitates retention of SREBPs in
ER. Cell. 110:489–500. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dennis LK, Lynch CF and Torner JC:
Epidemiologic association between prostatitis and prostate cancer.
Urology. 60:78–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dylgjeri E, McNair C, Goodwin JF, Raymon
HK, McCue PA, Shafi AA, Leiby BE, de Leeuw R, Kothari V, McCann JJ,
et al: Pleiotropic impact of DNA-PK in cancer and implications for
therapeutic strategies. Clin Cancer Res. 25:5623–5637. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Daniels NA, Ewing SK, Zmuda JM, Wilt TJ
and Bauer DC; Osteoporotic Fractures in Men (MrOS) research group,
: Correlates and prevalence of prostatitis in a large
community-based cohort of older men. Urology. 66:964–970. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang J, Li J, Yunxia Z, Zhu H, Liu J and
Pumill C: The role of prostatitis in prostate cancer:
Meta-analysis. PLoS One. 8:e851792013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dillner J, Knekt P, Boman J, Lehtinen M,
Af Geijersstam V, Sapp M, Schiller J, Maatela J and Aromaa A:
Sero-epidemiological association between human-papillomavirus
infection and risk of prostate cancer. Int J Cancer. 75:564–567.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nelson WG, De Marzo AM and Isaacs WB:
Prostate cancer. N Engl J Med. 349:366–381. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Taylor ML, Mainous AG III and Wells BJ:
Prostate cancer and sexually transmitted diseases: A meta-analysis.
Fam Med. 37:506–512. 2005.PubMed/NCBI
|
|
30
|
Sutcliffe S, Giovannucci E, De Marzo AM,
Leitzmann MF, Willett WC and Platz EA: Gonorrhea, syphilis,
clinical prostatitis, and the risk of prostate cancer. Cancer
Epidemiol Biomarkers Prev. 15:2160–2166. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wagenlehner FM, Elkahwaji JE, Algaba F,
Bjerklund-Johansen T, Naber KG, Hartung R and Weidner W: The role
of inflammation and infection in the pathogenesis of prostate
carcinoma. BJU Int. 100:733–737. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cheng I, Witte JS, Jacobsen SJ, Haque R,
Quinn VP, Quesenberry CP, Caan BJ and Van Den Eeden SK:
Prostatitis, sexually transmitted diseases, and prostate cancer:
The California Men's health study. PLoS One. 5:e87362010.
View Article : Google Scholar : PubMed/NCBI
|
